在比勒陀利亚,在服用他类药物的患者中,对失脂症的知识和生活方式的修改
Thandazile Z September1, John V Ndimande1, Henry I Okonta1
1Department of Family Medicine and Primary Health Care, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
概括
患有失脂血症的患者尽管知识不够丰富,但改变了他们的生活方式,这凸显了持续患者教育的必要性. 这项研究集中在比勒陀利亚卫生中心的他类药物使用者身上.
科学领域:
- 心血管健康 心血管健康
- 公共卫生 公共卫生
- 临床药房 临床药房
背景情况:
- 脱脂症是心血管疾病的主要危险因素,导致近一半的非传染性疾病.
- 评估患者的知识和生活方式实践对于管理失脂血症至关重要.
- 这项研究侧重于在南非比勒陀利亚的一个社区卫生中心接受他类药物治疗的患者.
研究的目的:
- 评估使用他类药物的患者中关于失脂症的知识和生活方式修改实践.
- 识别患者理解和遵守推的生活方式变化的潜在差距.
- 为针对性健康教育策略提供信息,用于治疗失脂血症.
主要方法:
- 采用了一种描述性的横截面研究设计.
- 数据采集使用结构化,管理和试点调查问卷.
- 这项研究包括了268名在比勒陀利亚的Phedisong 4社区卫生中心的参与者.
主要成果:
- 参与者的平均年龄为60.1岁,女性患病率高 (70.2%),超重者 (44.8%),高血压患者 (92.2%).
- 尽管知识普遍较差,但66.3%的参与者报告说他们改变了生活方式.
- 在缺乏知识和不良实践之间发现了显著的关联 (p < 0.001).
结论:
- 在超过一半的参与者中,缺乏关于失脂症的具体信息并没有妨碍改变生活方式,这可能是由于伴随性高血压的高发病率.
- 持续对患者进行关于失脂血症,其管理和生活方式调整的教育是必不可少的.
- 卫生教育应通过不同道在比勒陀利亚的各个卫生机构提供.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.7K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Angina IV: Management
493
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655


